Medicilon IncMedicilon IncMedicilon IncMedicilon Inc
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact

Factors Affecting Pharmacokinetics of Drugs

Home Featured Stories
NextPrevious

Factors Affecting Pharmacokinetics of Drugs

By medicilon | Featured Stories | 14 August, 2017 |

Factors Affecting ADME

There are four factors that will affect the pharmacokinetic drugs test: water-solubility; fat-soluble; dissociation degree and molecular weight.

Pharmacokinetic is a quantitative study of drugs in the body absorption, distribution, metabolism and excretion of the law.  The use of mathematical principles and methods to explain the plasma concentration with time changes in a discipline.

Water is the carrier of drug transport and the body of the medium. Drugs in the absorption site must have a certain degree of water solubility in a dissolved state, so that can be absorbed. Therefore, the drug is required to have certain water solubility. Polarity (the introduction of polar groups can increase water solubility), crystal form (the impact of drug bioavailability is more and more attention), the melting point of the solubility, thus affecting the absorption of drugs, affecting bioavailability.

Cell membrane of the double lipid layer structure requires a certain lipid-soluble drugs can penetrate the cell membrane. Come in (some fat-soluble), get out (some water-soluble).  Dissolve easily dissociable groups such as carboxyl groups. Through the modification of chemical structure, the introduction of fat-soluble groups or side chains, can improve the drug fat-soluble, promote drug absorption and improve bioavailability.

factors affecting adme

Drugs can only pass through biofilm in molecular form. Biofilm itself with a charge, phase suction, into the come, get out; reprimand: not come. Ions with hydration, the drug molecule volume increases, cannot pass through the biofilm microspores. The greater the dissociation is, the worse the absorption.

The degree of dissociation is related to the dissociation constant of the drug and the pH of the absorption site. The dissociation degree of the same drug in different parts is different and the degree of absorption is different. Weak acid drug dissociation in the stomach is small, easy to be absorbed; in the intestine, weak alkaline drug dissociation is small, so it is the weak alkaline drug absorption site.

Strong acid and alkali drugs and ionic drugs are difficult to absorb, as well as difficult to come out after entering the cell.

Excretion is the process of drug excreted from the body. The kidneys are the main organs of drug excretion. Protracted by the kidneys excreted drugs in the renal tubules can be reabsorption, so that the role of drug extension. Re-absorption by the urine pH effect, the application of acidic or alkaline drugs, changes the pH of the urine, can reduce renal tubular reabsorption of drugs.

Medicilon’s pharmacokinetics department offers the clients a broad spectrum of high quality of services in the areas of in vitro ADME. With SPF animal laboratory, Medicilon can provide you, such as mice, rats, rabbits and other different species of animal pharmacokinetics experiments and the route of administration and the way is also a variety of intravenous, gavage, subcutaneous and abdominal wait.

Related Articles:

ADME Pharmacokinetics Studies

Pharmacokinetics and Pharmacodynamics (PK/PD) Studies

Drug Metabolism and Pharmacokinetics (DMPK) Studies

Pharmacokinetic Research Services

ADME, factors affecting adme, Pharmacokinetics of Drugs
NextPrevious

News

  • Medicilon Events
  • Media Coverage
  • Featured Stories

Tags

ADME (11) Analytical Method Development (2) animal model (3) Animal Models (46) API (3) API process (3) BIAcore 8K (3) bioanalytical testing (3) Clinical Trails (2) consistency evaluation (3) COVID-19 (3) CRO (13) CRO company (8) CRO industry (6) diabetes treatment (3) Drug Discovery (7) drug safety cro (2) Drug Safety Evaluation (3) Elisa Assay (4) Formulation Research (3) GLP (3) green chemistry (3) IND (2) IND Application (3) IND Filing (5) IPO (3) LC-MS (4) Ligand Binding Assay (4) Medicilon Inc. (2) neurological disease (4) neurological diseases (4) neurological disorder (5) neurological disorders (4) PDX model (3) Peptide Drugs (3) Pharmacokinetics (7) pharmacokinetics research (6) Preclinical Research (6) PROTAC (4) Protein expression (4) Protein Purification (8) SAPA (5) Synthetic Biology (4) T cell (3) Western Blot Analysis (2)

Top Posts

  • 14 August, 2017

    Factors Affecting Pharmacokinetics of Drugs

  • 14 October, 2016

    Preclinical Drug Development Process

  • 14 February, 2017

    IND Enabling Studies FDA

Share

About Us

  • Medicilon Overview
  • Executive Team
  • CEO Message
  • Company History
  • Corporate Culture
  • Honor

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

Customer Center

  • Customer Reviews
  • Download Center
  • Intellectual Property Protection
  • New Models of Collaboration

Contact Us

Shanghai Medicilon Inc.

Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China
Email: Marketing@medicilon.com
Website: www.medicilon.com

Copyright 2017 Shanghai Medicilon inc. | All Rights Reserved Privacy Policy
  • Languages
  • 中国日本대한민국
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact
Medicilon Inc